Showing results (1-10 of 7) with videos related to
Sort By:
Pageof 1
International Journal of Surgical Pathology|April 28, 2025
Primary de novo Epidermal Growth Factor Receptor Mutant Small Cell Lung Carcinomas: Clinicopathological Study of a Rare Entity Presenting in Treatment-Naïve Setting with Review of LiteratureAruna Nambirajan, Amber Rathor, Hemavathi Baskarane, et al.The American Journal of Surgical Pathology|April 29, 2022
IDH1/2 Mutations in Sinonasal Undifferentiated Carcinomas : Previously Undescribed IDH2 R172K and R140x VariantsAanchal Kakkar, Amber Rathor, Subiyathul Farah Ashraf, et al.Journal of the American Society of Cytopathology|May 4, 2024
Pleural effusion supernatant: a reliable resource for cell-free DNA in molecular testing of lung cancerShilpi Thakur, Amber Rathor, Surabhi Jain, et al.Archives of Pathology & Laboratory Medicine|December 6, 2021
SMARCA4/BRG1-Deficient Sinonasal CarcinomaAanchal Kakkar, Subiyathul Farah Ashraf, Amber Rathor, et al.Journal of Cancer Research and Clinical Oncology|July 27, 2024
'Plasma first' approach for detecting epidermal growth factor receptor mutation in advanced non-small cell lung carcinomaAmber Rathor, Prabhat Singh Malik, Pranay Tanwar, et al.Virchows Archiv : an International Journal of Pathology|February 21, 2025
Baseline retinoblastoma transcriptional corepressor 1 (Rb1) functional inactivation is a pre-requisite but not sufficient for small-cell histological transformation in epidermal growth factor receptor (EGFR) mutant lung adenocarcinomas post-tyrosine kinase inhibitor therapyAruna Nambirajan, Amber Rathor, Hemavathi Baskarane, et al.Scientific Reports|March 6, 2023
Mapping the immune landscape in small cell lung cancer by analysing expression of immuno-modulators in tissue biopsies and paired blood samplesRimlee Dutta, Amber Rathor, Hanuman Prasad Sharma, et al.Pageof 1